Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/45838
Title: Nociplastic pain: towards an understanding of prevalent pain conditions.
Authors: Fitzcharles M.-A.;Cohen S.P.;Clauw D.J.;Littlejohn G.;Usui C.;Hauser W.
Monash Health Department(s): Rheumatology
Institution: (Littlejohn) Department of Rheumatology and Department of Medicine, Monash Health and Monash University, Clayton, Melbourne, VIC, Australia
(Fitzcharles) Department of Rheumatology and Alan Edwards Pain Management Unit, McGill University, Montreal, QC, Canada
(Cohen) Department of Psychiatry and Behavioral Sciences and Department of Anesthesiology and Critical Care Medicine, Neurology and Physical Medicine and Rehabilitation at Johns Hopkins Hospital, Baltimore, MD, United States
(Cohen) Uniformed Services University of the Health Sciences, Bethesda, MD, United States
(Clauw) Departments of Anesthesiology, Medicine, and Psychiatry, Chronic Pain and Fatigue Research Center, the University of Michigan Medical School, Ann Arbor, MI, United States
(Usui) Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan
(Hauser) Department Internal Medicine I, Klinikum Saarbrucken, Saarbrucken, Germany
(Hauser) Department of Psychosomatic Medicine and Psychotherapy, Technische Universitat Munchen, Munchen, Germany
Issue Date: 4-Nov-2021
Copyright year: 2021
Publisher: Elsevier B.V.
Place of publication: United Kingdom
Publication information: The Lancet. 397(10289) (pp 2098-2110), 2021. Date of Publication: 29 May 2021.
Journal: The Lancet
Abstract: Nociplastic pain is the semantic term suggested by the international community of pain researchers to describe a third category of pain that is mechanistically distinct from nociceptive pain, which is caused by ongoing inflammation and damage of tissues, and neuropathic pain, which is caused by nerve damage. The mechanisms that underlie this type of pain are not entirely understood, but it is thought that augmented CNS pain and sensory processing and altered pain modulation play prominent roles. The symptoms observed in nociplastic pain include multifocal pain that is more widespread or intense, or both, than would be expected given the amount of identifiable tissue or nerve damage, as well as other CNS-derived symptoms, such as fatigue, sleep, memory, and mood problems. This type of pain can occur in isolation, as often occurs in conditions such as fibromyalgia or tension-type headache, or as part of a mixed-pain state in combination with ongoing nociceptive or neuropathic pain, as might occur in chronic low back pain. It is important to recognise this type of pain, since it will respond to different therapies than nociceptive pain, with a decreased responsiveness to peripherally directed therapies such as anti-inflammatory drugs and opioids, surgery, or injections.Copyright © 2021 Elsevier Ltd
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/S0140-6736%2821%2900392-5
PubMed URL: 34062144 [http://www.ncbi.nlm.nih.gov/pubmed/?term=34062144]
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/45838
Type: Review
Subjects: chronic pain
cognitive behavioral therapy
complex regional pain syndrome
disease course
disease predisposition
emotion
face pain
family history
fibromyalgia
headache
health education
musculoskeletal pain
neurophysiology
nociceptive pain
pain
pain assessment
physical abuse
sexual abuse
social psychology
visceral pain
analgesic agent
nociplastic pain
Appears in Collections:Articles

Show full item record

Page view(s)

40
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.